European AxSpA Guidelines Reflect Recent Changes in Drug Therapy

Recommendations for the management of patients with axial spondyloarthritis (axSpA) emphasize both pharmacologic and nonpharmacologic therapies.

Related Keywords

California ,United States ,Moonlake ,Netherlands ,Denmark ,Copenhagen ,Køavn ,San Francisco ,Lianne Gensler ,Eli Lilly ,University Of California ,American College Of Rheumatology ,Novartis ,Assessment Of Spondyloarthritis International Society ,European Alliance Of Associations ,Pfizer ,Leiden University Medical Center ,Sofia Ramiro ,European Alliance ,Spondyloarthritis International Society ,Closer Look ,New Recommendations ,Medscape Medical ,Merck Sharp ,Presented June ,Ankylosing Spondylitis ,Ankylosing Spondylitis Bechterews Disease ,Clinical Guidelines ,Guidelines ,Europe ,European ,Psoriasis ,Arthritis ,Oint Inflammation ,Biologic Therapy ,Inflammatory Bowel Disease ,Nflammatory Bowel Disease Ibd ,Bd ,Intraocular Inflammation ,Nonpharmacologic ,Uveitis ,Disease Modifying Antirheumatic Drugs Dmards ,Mard Disease Modifying Antirheumatic Drug ,Rheumatoid Arthrit ,